Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (79,336)	$ (71,704)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,418	1,133
Share-based compensation	12,856	4,259
Bad debt expense	3,014	201
Write-down of inventory to net realizable value	646	1,581
Preferred stock warrant liability adjustment	0	5,578
Common stock warrant liability adjustment	(6,337)	(15,745)
Amortization of right of use assets	1,253
Gain on loan forgiveness	0	2,098
Interest expense from contingent beneficial conversion feature	0	26,061
Other adjustments, net	307	725
Changes in assets and liabilities:
Accounts receivable	(8,504)	(144)
Prepaid expenses and other assets	6,226	(10,493)
Inventory	(1,181)	(11,649)
Accounts payable and accrued and other expenses	(10,720)	32,117
Other, net	(1,022)	(378)
Net cash used in operating activities	(81,380)	(40,556)
Cash flows from investing activities
Purchase of property and equipment	(636)	(969)
Purchase of intangible assets	(929)	(1,051)
Net cash used in investing activities	(1,565)	(2,020)
Cash flows from financing activities
Proceeds from short-term borrowings	44,530	13,708
Payments of short-term borrowings	(40,026)	(21,194)
Proceeds from long-term borrowings	0	5,000
Payments of long-term borrowings	(6,000)	(1,000)
Proceeds from reverse recapitalization and PIPE financing, net of $0 and $11,610, respectively, of transaction costs	0	133,889
Payments for cash payout of stock options as result of the Merger (Note 3)	0	(9,890)
Other, net	618	108
Net cash provided by (used in) financing activities	(878)	120,621
Net change in cash and cash equivalents	(83,823)	78,045
Cash and cash equivalents at beginning of period	95,054	17,009
Cash and cash equivalents at end of period	11,231	95,054
Supplemental disclosure of cash flow information:
Cash paid for interest	1,075	1,773
Supplemental disclosure of non-cash financing activities:
Conversion of redeemable convertible preferred stock to common stock	0	47,188
Conversion of related party convertible notes to common stock	0	33,183
Common stock warrants received as part of the Merger (Note 3)	$ 0	$ 22,806